SCC pseudoprogression in a patient receiving immunotherapy and oncolytic virus combination therapy

Authors

A. Befon
A. Stratigos
Efthymia Soura (ORCID: https://orcid.org/0000-0003-0324-5647)
Thomas Hanke (ORCID: https://orcid.org/0000-0001-7202-9468)
M. Plaka
E. Doxopoulou

Institutions

XLIM (FR)
Andreas Sygros Hospital (GR)

Publication Details

Journal: EJC Skin Cancer
Published: 2025-01-01
DOI: https://doi.org/10.1016/j.ejcskn.2025.100715
Primary Topic: Virus-based gene therapy research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

SCC pseudoprogression in a patient receiving immunotherapy and oncolytic virus combination therapy

A. Befon, A. Stratigos, Efthymia Soura, Thomas Hanke et al.

Jan 1, 2025

EJC Skin Cancer

Virus-based gene therapy research

article

SCC pseudoprogression in a patient receiving immunotherapy and oncolytic virus combination therapy

A. Befon, A. Stratigos, Efthymia Soura, Thomas Hanke, M. Plaka, E. Doxopoulou

January 1, 2025article en

Abstract

No abstract available for this paper.

EJC Skin CancerVol. 3

XLIM (FR), Andreas Sygros Hospital (GR)

Openalex Percentile: Top 92%

Virus-based gene therapy research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

SCC pseudoprogression in a patient receiving immunotherapy and oncolytic virus combination therapy — A. Befon, A. Stratigos, et al. · EJC Skin Cancer (2025) | TGRS Research Map | TGRS